Hypertension is one of the most prevalent non-transmittable diseases in the world, with 29% of the world's population expected to suffer from the condition by 2025. Despite substantial advances in ...

Understanding the mechanism by which chronic high blood pressure induces vascular disease is of fundamental importance for prevention of the adverse consequences of hypertension. Clinical and ...

Pulmonary arterial hypertension (PAH) is a devastating disease characterized by arteriopathy in the small to medium-sized distal pulmonary arteries, often accompanied by infiltration of inflammatory ...

Further investigation on the pathogenesis and treatment of patients with schistosome-associated pulmonary arterial hypertension (Sch-PAH) may lead to improved symptoms and higher rates of survival. A ...

Angiotensinogen is the sole precursor of angiotensin peptides and has a key role in the pathogenesis of hypertension. Zilebesiran, an investigational RNA interference therapeutic agent with a ...

In a recent study published in the Annals of Internal Medicine, researchers are advising healthcare professionals to screen for primary aldosteronism more often and consider it as a possible primary ...

Expert Rev Cardiovasc Ther. 2012;10(11):1367-1373. The elderly merit special consideration for BP measurement. These hypertensive patients are prone to have autonomic failure with postural hypotension ...

—Investigators from the U.S. and U.K have identified neutrophil elastase (NE) and its inhibitor elafin as possible biomarkers in the pathogenesis of pulmonary arterial hypertension (PAH). “An ...

A gospel truth in ophthalmology has been that people of African ancestry are more likely to develop glaucoma, but a new study clouded the picture. The long-term cohort study has identified modifiable ...

SOUTH BEND, Ind.–Indiana University School of Medicine researchers at the school’s South Bend regional campus, in collaboration with colleagues at the University of Notre Dame, have identified a new ...

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...